Biogen Inc (NASDAQ:BIIB)

199.45
Delayed Data
As of 3:59pm ET
 -0.20 / -0.10%
Today’s Change
187.16
Today|||52-Week Range
468.55
-16.87%
Year-to-Date
Krensavage Asset Management, LLC Buys 2, Sells 3 in 1st Quarter
May 19 / GuruFocus News - Paid Partner Content
3 Healthcare Stocks That Are Too Cheap to Ignore
May 11 / MotleyFool.com - Paid Partner Content
3 Dividend Stocks That Should Pay You for the Rest of Your Life
May 16 / MotleyFool.com - Paid Partner Content
How Are Biotech ETFs Reacting to These Q1 Earnings Releases?
May 10 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close199.65
Today’s open201.03
Day’s range198.77 - 203.87
Volume19,141
Average volume (3 months)1,274,716
Market cap$29.2B
Data as of 3:59pm ET, 05/23/2022

Growth & Valuation

Earnings growth (last year)-58.03%
Earnings growth (this year)-19.61%
Earnings growth (next 5 years)-4.00%
Revenue growth (last year)-15.81%
P/E ratio20.4
Price/Sales3.45
Price/Book2.69

Competitors

----
ILMNIllumina Inc+1.59+0.65%
BMRNBiomarin Pharmaceuti...+0.69+0.87%
TECHBio-Techne Corp-1.92-0.52%
Data as of 4:18pm ET, 05/23/2022

Financials

Next reporting dateJuly 26, 2022
EPS forecast (this quarter)$4.09
Annual revenue (last year)$10.4B
Annual profit (last year)$1.6B
Net profit margin14.96%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Cambridge, Massachusetts

Forecasts